X4 Pharmaceuticals (XFOR) Selling, General & Administrative (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 1.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -37.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 2.17 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 493.70 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -1.52 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 647.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 322.55 Mn |
| 10 | X4 Pharmaceuticals | 182.28 Mn | 182.28 Mn | 2.20 Mn | -26.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26.27 Mn |
| Sep 30, 2025 | 11.59 Mn |
| Jun 30, 2025 | -28.21 Mn |
| Mar 31, 2025 | -38.25 Mn |
| Dec 31, 2024 | 15.15 Mn |
| Sep 30, 2024 | -35.06 Mn |
| Jun 30, 2024 | 13.28 Mn |
| Mar 31, 2024 | -37.29 Mn |
| Dec 31, 2023 | -133.10 Mn |
| Sep 30, 2023 | 8.13 Mn |
| Jun 30, 2023 | 10.20 Mn |
| Mar 31, 2023 | 7.24 Mn |
| Dec 31, 2022 | 6.56 Mn |
| Sep 30, 2022 | 6.04 Mn |
| Jun 30, 2022 | 6.75 Mn |
| Mar 31, 2022 | 7.66 Mn |
| Dec 31, 2021 | 7.14 Mn |
| Sep 30, 2021 | 5.93 Mn |
| Jun 30, 2021 | 5.80 Mn |
| Mar 31, 2021 | 5.83 Mn |
| Dec 31, 2020 | 5.36 Mn |
| Sep 30, 2020 | 5.60 Mn |
| Jun 30, 2020 | 5.32 Mn |
| Mar 31, 2020 | 4.67 Mn |
| Dec 31, 2019 | 3.91 Mn |
| Sep 30, 2019 | 4.38 Mn |
| Jun 30, 2019 | 4.56 Mn |
| Mar 31, 2019 | 4.78 Mn |
| Dec 31, 2018 | 3.37 Mn |
| Sep 30, 2018 | 2.39 Mn |
| Jun 30, 2018 | 1.62 Mn |
| Mar 31, 2018 | 1.37 Mn |
| Dec 31, 2017 | -448,000.00 |
| Sep 30, 2017 | 2.46 Mn |
| Jun 30, 2017 | 1.74 Mn |
| Mar 31, 2017 | 1.44 Mn |